CBD Life Sciences, Inc. (OTC – CBDL) is not your typical CBD company. With a robust online business, brick and mortar location, combined with a diverse offering in key, in-demand categories, CBDL is poised to continue to generate strong sales growth ahead.
|
Read more...
|
In a matter of weeks, China Xiangtai Food Corp., Ltd (NASDAQ – PLIN) has made an acquisition and entered into a JV—both steps prompt major forecast increases, with a price target upgrade under review.
|
Read more...
|
While the industry zigs (or contracts) American Energy Partners, Inc. (OTC – AEPT) zags (grows like crazy). AEPT is enjoying record sales growth and solid profits. The whole complexion and profile, are changing and management confirmed that new M&A could be on the horizon which could take the valuation to a new level.
|
Read more...
|
Nascent Biotech (OTC – NBIO) is slated to release in vitro studies that demonstrate its lead candidate may have an impact in treatment of coronaviruses as Pritumumab may have the ability to interfere with the virus’ binding to target cells, thus possibly eliminating deadly effects.
|
Read more...
|
Data443 Risk Mitigation, Inc. (OTC - ATDS) is oversold, misunderstood, offers great value and significant upside potential, per our new 6 month price target
|
Read more...
|
US-based and China focused Oranco, Inc. (OTC - ORNC) is growing top-line, very profitable, tradex at low price/book ,and is set yo execute M&A and an uplist later this year.
|
Read more...
|
In our view, if leading China pork processor China Xiangtai Food Co., Ltd, (NASDAQ - PLIN) were to engage in a roll up strategy it could leap past its 52-week high. If it stayed on its current path, we believe 66% upside still lies ahead.
|
Read more...
|
With Surge Holdings (OTC -SURG) set to enjoy a 300% increase in revenue to $100M+ in 2020, we have raised our forecasts and price target.
|
Read more...
|
American Premium Water Corp (OTC - HIPH) just announced a transformational event for the company, going forward. Since our initiation a week ago, the stock is up 28% and based on the latest news we continue to affirm our target price and ivestment thesis.
|
Read more...
|
With multiple products in the consumer products arena, particularly in the fast-growing, high profile CBD-infused products arena, HIPH is well positioned to generate meaningful sales across multiple sectors, in 2020.
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
Page 4 of 43 |